QUANTUM X LABS INC. annual report, FY2013

Business context and reporting period

The supplied filing is Zaxis International Inc.’s Form 10-K for the fiscal year ended December 31, 2013; it does not identify Quantum X Labs Inc. as the registrant. Verify that this is the intended filing. Zaxis reported no operating business and described itself as a shell company seeking a business combination. It had not identified a target business or industry.

Financial results and liquidity

Metric20132012
Revenue$0$0
General and administrative expense$41,200$40,500
Interest expense$10,200$10,200
Net loss$51,400$50,700
Operating cash used$5,950$3,750
Cash at year-end$0$0
Total assets$0$0
Total liabilities$278,779$227,379

There were no revenue or operating margins to report. The 2013 operating cash outflow was funded by $5,950 of related-party advances. Year-end current liabilities included $85,000 in convertible notes, $32,050 in accrued interest, and $161,729 due to related parties. The notes bear 12% annual interest and were extended to mature December 31, 2014; their conversion prices are $0.10 and $0.03 per share. The company reported no current assets, so it had no balance-sheet liquidity.

Shares outstanding were 1,695,126 at year-end. Basic and diluted loss per share was $0.03 in both years. The filing reports no off-balance-sheet arrangements or contractual obligations.

Changes, outlook, and risks

Net loss increased by $700 year over year, principally reflecting a $700 increase in general and administrative expense, which the company attributed mainly to higher accounting fees. Operating cash used increased by $2,200. Liabilities rose by $51,400, while cash remained zero.

Management’s objective was to pursue a business combination, potentially funded with stock, debt, or both. No target, transaction, or specific forecast was provided. Management said it believed actions to obtain additional equity financing could support continued operations, but financing was not assured. The auditor’s opinion was unqualified but included an explanatory going-concern paragraph, citing recurring losses, negative operating cash flow, and no revenue as substantial doubt about the company’s ability to continue as a going concern.

Management and affiliated parties were providing or had agreed to provide interim funding, but the filing says there was no written agreement requiring management to fund expenses. The company warned that it might need financing to meet reporting and administrative costs, and that it might issue restricted shares in lieu of cash. A business combination could substantially dilute existing holders, change control, or create debt-service and refinancing risks. Other stated risks include dependence on a single prospective business, limited resources and competition for targets, management conflicts and limited time commitment, inability to assess an unidentified target’s risks, and limited OTCQB trading liquidity.

Disclosure controls and internal control over financial reporting were reported ineffective as of December 31, 2013 because of inadequate segregation of duties. The auditor did not attest to internal control effectiveness. No legal proceedings were reported. The company stated it did not expect to pay dividends in the foreseeable future.

Important facts for investors to verify

  • Confirm issuer identity: the filing is for Zaxis International Inc., not Quantum X Labs Inc.
  • Confirm the reported ownership figures: the filing states management owns 82% in one section, while the beneficial-ownership table reports 83% for Ivo Heiden.
  • Reconcile the accumulated-deficit figures: the balance sheet reports $(400,194) at December 31, 2013, while the statement of stockholders’ deficit reports $(400,894); the reported total shareholders’ deficit is $(278,779).
  • Assess the company’s ability to continue funding operations, including the status and terms of related-party support, financing plans, and the convertible notes due December 31, 2014.
  • Review any subsequent business-combination developments and the status of disclosure-control remediation; no target or specific outlook was disclosed in this filing.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.